2,5-diketopiperazine,
2,5-dioxopiperazine,
cyclo(Gly-Gly),
cyclo(glycylglycyl),
Piperazine-2,5-dione,
2,5-Piperazinedione,
106-57-0,
2,5-Dioxopiperazine,
2,5-DIKETOPIPERAZINE,
Cyclodiglycine,
Cycloglycylglycine,
Cyclo(glycylglycyl),
Glycylglycine lactam,
Diglycolyl diamide,
Glycine, bimol. cyclic peptide,
alpha,gamma-Diacipiperazine,
Glycine, N-glycyl-, cyclic peptide,
MFCD00006009,
NSC 26345,
Cyclic(glycylglycyl),
UNII-240L69DTV7,
EINECS 203-411-5,
BRN 0112112,
.alpha.,.gamma.-Diacipiperazine,
CHEBI:16535,
BXRNXXXXHLBUKK-UHFFFAOYSA-N,
240L69DTV7,
NSC26345,
Glycine anhydride, 98%,
1,4-diazaperhydroine-2,5-dione,
Glycocoll Anhydride,
cyclo-(Gly-Gly),
GLYCINEANHYDRIDE,
Glycine, cyclic peptide,
piperazine-2,5-quinone,
AC1L1PM9,
SCHEMBL66638,
5-24-05-00294 (Beilstein Handbook Reference),
CHEMBL125229,
TPC-A002,
DTXSID8059342,
CTK3J2091,
KS-00000UXZ,
2,5-Diazacyclohexane-1,4-dione,
Glycine anhydride, cyclic dipeptide,
BCP20475,
ZINC1529518,
7199AF,
ANW-43502,
BBL015186,
LS-404,
NSC-26345,
SBB079702,
STK741583,
AKOS001056505,
Glycine anhydride; 2,5-Piperazinedione,
MCULE-7134033861,
NE31084,
PS-4716,
RTR-001311,
AJ-26613,
CJ-23918,
Piperazine-2,5-dione (Glycine Anhydride),
AB1003366,
ST4016141,
TR-001311,
CS-0046695,
EU-0051025,
FT-0610501,
G0100,
ST24048923,
CYCLO-GLYCYLGLYCINE (3,3,6,6-D4),
C02777,
G-4600,
23614-EP2272972A1,
23614-EP2272973A1,
23614-EP2277872A1,
23614-EP2280004A1,
23614-EP2280020A1,
23614-EP2280021A1,
23614-EP2284178A2,
23614-EP2284179A2,
23614-EP2287152A2,
23614-EP2305808A1,
23614-EP2314298A1,
AC-907/30002028,
Z56854487,
F0278-0016,
Glycine anhydride;oxiracetaM related substance ISF3890,
I14-109680,
A0783/0036652,
2,5-DIKETOPIPERAZINE (SEE ASPARTAME (22839-47-0)),
InChI=1/C4H6N2O2/c7-3-1-5-4(8)2-6-3/h1-2H2,(H,5,8)(H,6,7,
Diketopiperazine,
GLYCINE ANHYDRIDE,
diglycolyldiamide,
C4H6N2O2,
Glycine anhydride, 99% 25g,
CID7817,
C4-H6-N2-O2,
ZINC01529518,